Dendritic Cell Therapy and what's behind

What are dendritic cells?

Dendritic cell therapy is an advanced form of immunotherapy that turns your body’s natural defenders into targeted cancer fighters. Think of dendritic cells as the scouts or conductors of your immune system. Their main job is to sample foreign invaders, like cancer cells, and present those targets directly to your T-cells, ordering them to attack. In simple terms, they teach your body how to recognize and fight the disease from within.

This groundbreaking approach traces back to 1973, when Canadian scientist Dr. Ralph Steinman first discovered dendritic cells. He spent decades researching how to train these cells outside the body to create personalized vaccines. In a remarkable turn of events, Dr. Steinman used custom dendritic cell therapy to treat his own advanced pancreatic cancer, extending his life and earning the Nobel Prize in 2011. Today, Germany stands at the forefront of providing these advanced, tailored medical immunotherapies for patients worldwide.

How does dendritic cell vaccine work?

Dendritic cell therapy acts as an intelligent bridge between your body’s natural surveillance network and its frontline defense force. In a healthy organ, dendritic cells serve as specialized intelligence gatherers. They constantly sweep through tissues, collect fragments of dangerous invaders, and deliver those distinct biological markers to your T-cells—the primary attack units of your immune system—instructing them where to strike.

Cancer, however, frequently erects biological cloaks. Tumors release chemical signals that paralyze local dendritic cells or conceal surface markers, allowing malignant cells to multiply undetected right under your immune system’s watch.

This treatment overcomes that stealth tactic through a clear, personalized sequence:

Harvesting Precursors: A routine outpatient blood draw collects immature immune cells (monocytes). Removing them from the body shields them from the tumor’s suppressive signals.

Laboratory Training: In a specialized cleanroom facility, these monocytes mature into fully functional dendritic cells. Scientists introduce them to your specific tumor markers, effectively providing them with a clear biological “target card.”

Systemic Re-introduction: Once fully activated and primed, your custom dendritic cells are injected back into your body. They naturally migrate to your lymph nodes—the central command hubs of your immune system.

Inside the lymph nodes, the dendritic cells present the target markers to your T-cells. Newly activated T-cells multiply rapidly, enter the bloodstream, and seek out matching cancer cells everywhere in the body while leaving normal, healthy tissue untouched.

Building Lasting Memory: Beyond attacking existing cancer, this interaction trains your body to store the tumor profile in its immunological memory, helping your defenses stay alert against future recurrences. However, 2-4 vaccine cycles are necessary.

Why ICD with Newcastle Disease Virus is Necessary Before Receiving the Vaccine

Tumor cells frequently cloak themselves to evade detection, creating an immunological environment where your body’s defenses remain unaware of the threat.

To create a powerful personalized vaccine, your dendritic cells need two vital elements: the exact antigen signature of your tumor and a strong biochemical alarm (the “danger signal”)

Here is why ICD with Newcastle Disease Virus (NDV) plays an essential role in this process:

Releasing Target Antigens: When NDV causes selective tumor cell breakdown (oncolysis), it breaks open the cancer cells and exposes internal proteins. These antigens provide the precise template used to train the dendritic cells collected in Step 3.

Generating the “Danger Signal”: The viral activity mimics a natural infection around the tumor, releasing alarm signals that awaken dormant immune cells. This transforms quiet, unresponsive tissue into an active immune response site.

By combining the monocytes gathered during blood collection with the antigens and alarm signals generated by NDV therapy, your personalized vaccine gains the exact specificity required to mobilize your T-cells effectively against the disease.
.

The Memory Effect of combined Immunotherapy

Imagine giving your immune system a permanent upgrade against cancer. When facing a tough diagnosis, standard treatments often focus only on the immediate fight. However, your body also needs a long-term defense strategy that keeps protecting you far into the future.

Fortunately, combining 2 to 4 cycles of dendritic cell vaccine with oncolytic viro-therapy using the Newcastle disease virus creates a powerful synergy. The Newcastle virus selectively infects cancer cells, causing them to burst open and reveal key markers that were previously hidden from your immune defenses.

Dendritic cells act as your body’s master intelligence officers. They gather these revealed cancer markers and present them directly to your T-cells, effectively training your immune army to recognize the enemy with pinpoint precision.

As a result, going through 2 to 4 targeted cycles of dendritic cell vaccine unlocks what scientists call the “memory effect.” Instead of forgetting the threat once treatment pauses, your T-cells store the unique signature of the tumor. They remain on high alert throughout your bone marrow, ready to hunt down lingering or returning cancer cells indefinitely.

This combined approach of dendritic cell therapy and viral therapy offers more than a temporary shield—it builds a lasting immune memory to guard your health for the long haul.

Type of cancers we can treat with immunotherapy

Step-by-Step treatment sequence guide

STEP 1

Leukapheresis / Blood draw

Blood is drawn and monocytes (DC precursor cells) are separated via a gentle blood-filtering procedure. This takes approximately 2- 4 hours and is done in a specialized facility. Or a simple blood draw which takes 5 min.

STEP 2

DC Maturation

In a GMP-certified laboratory, monocytes are cultured for 8 days with cytokines (IL-4, GM-CSF) to develop into immature DCs, then matured with pro-inflammatory signals.

STEP 3

ICD Immunogenic cell death

Immunogenic Cell Death (ICD) with Newcastle virus refers to a specific, immunologically active form of tumor cell death one that does not simply eliminate cells quietly, but does so in a way that raises an immune alarm.

When tumor cells die through ICD, they release or expose a series of molecular signals called Damage-Associated Molecular Patterns (DAMPs). The most important of these include calreticulin (exposed on the cell surface), HMGB1 (released into the surrounding environment), and ATP. These signals act as “danger” and “eat me” flags that recruit and activate the DCs.

STEP 4

Tumor antigen loading

Mature DC’s are loaded with your-specific tumor antigens derived from the Immunogenic Cell Death (ICD) therapy with Newcastle Disease Virus (NDV) for cancer.

RESULT

Immunization

Injected DCs migrate to lymph nodes and present tumor antigens to naive T cells. “This activates tumor-specific cytotoxic T lymphocytes (CTLs) that travel to the tumor and attack cancer cells.”

The immune response generated by dendritic cell vaccine is “highly specific it targets” the individual molecular fingerprint of your own tumor.

However, this personalization is one of its key advantages over standard systemic therapies.

Find a clinic for Dendritic Cell Vaccine in Germany

Germany is renowned for its advanced medical treatments and state-of-the-art facilities, making it a top destination for patients seeking cutting-edge therapies like comprehensive immunotherapy. One of the leading organizations in this field is GermanyHealth.

Our offer includes all from A to Z including transportation if you need it. Hence, for a remote second opinion, book here. However, if you have high demand, we recommend booking our VIP Service Germany.

Also our patient service provides comprehensive support for international patients seeking treatment with dendritic cell vaccine for prostate cancer in Germany.

Expert Consultation and Treatment Planning: We provide expert medical consultation to determine the most appropriate treatment plan for each patient with prostate cancer to get the appropriate dendritic cell therapy.

Hospital and Clinic Coordination: We arrange treatment at some of Germany’s best hospitals and clinics specializing in the treatment of prostate cancer with modern Immunotherapies. Of course, you receive our onside service as well.

Travel and Accommodation Assistance: We assist with travel arrangements, visa applications, transportation in Germany, and accommodation, ensuring a smooth and stress-free experience.

Ongoing Patient Support: We offer continuous support throughout the treatment process, including follow-up care and communication with the clinic. Hence, we provide follow up service after you have left back home.

Innovative Dendritic Cell Vaccine